Interní Med. 2010; 12(2): 98-100
Giant cell arteriitis
- Interní oddělení, Revmatologická ambulance, Uherskohradišťská nemocnice a. s.
Giant cell arteriitis is disease from the group of large vesel vasculitis. This disease is more frequently in old age. Symptoms might be
nonspecific such as elevated temperature, decrease of weight or atypical headache. Main risk of late treatment is non-reversible loss
of eyesight. In the therapy the main drugs are still corticosteroids, alternatively can be used other imunosupresives or anti TNF alfa
antibodies.
Keywords: primary vasculitis, older age, eye disability, corticosteroids
Published: May 1, 2010 Show citation
References
- Bečvář R. Vaskulitidy v klinické praxi. Medprint, 1994; 45-88.
- Cantini F. Diagnosis and treatment of giant cell arthritis. Drug Aging 2008: 422-430.
Go to original source... 
Go to PubMed... - Kotík L. Revmatická polymyalgie a velkobuněčná arteriitida. Postgraduální medicína 2007, 9.
- Martinez-Taboada VM, a kol. A double blind placebo controlles trial of etanercept in patiens with giant cell arthritis. Ann Rheum Dis., 2008; 1165-1173.
- Pavelka K, a kol. Klinická revmatologie, Praha Galén, 2003: 294-295.
- Pavelka K, a kol. Farmakoterapie revmatických onemocnění, Grada, Praha 2005: 280.
- Pavelka K. Polymyalgia rheumatica a temporální arteriitida. Česká revmatologie 2001, 9.
- Pipitone N, Salvarani C. Improving therapeutic options for patiens with giant cell arthritis. Current Opinion Rheumatology 2008: 1496-1503. Go to original source... Go to PubMed...